Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1

Guardat en:
Dades bibliogràfiques
Publicat a:Hemasphere
Autors principals: Lukes, Julius, Winkowska, Lucie, Zwyrtkova, Martina, Starkova, Julia, Sramkova, Lucie, Stary, Jan, Trka, Jan, Zuna, Jan, Zaliova, Marketa
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2020
Matèries:
Letter
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665249/
https://ncbi.nlm.nih.gov/pubmed/33204999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000489
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars